COMMUNIQUÉS West-GlobeNewswire

301,521 Orion Corporation A shares converted into B shares

02/05/2025 - 08:00

ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 2 MAY 2025 at 9.00 EEST 301,521 Orion Corporation A shares converted into B shares In accordance with Section [...]

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

02/05/2025 - 02:14

Company Announcement Decision to submit based on a positive overall response rate (ORR) (p-value < 0.0001), one of the dual primary endpoints in the Phase 3 EPCORE ® FL-1 trial Full results from the trial will be [...]

OBI Pharma reçoit l’approbation de la FDA à la suite de sa demande d’étude clinique de la Phase I/II pour OBI-902, un CAM ciblant Trop-2

02/05/2025 - 04:56

OBI-902 est le premier CAM utilisant la technologie CAM brevetée GlycOBI® d’OBI TAIPEI, Taïwan, 02 mai 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (« OBI »), un laboratoire d’oncologie au stade clinique (4174.TWO), [...]

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update

01/05/2025 - 22:01

Company reports $74.1 million in Q1 total revenue, reflecting 61% growth year-over-year IBSRELA net product sales revenue of $44.4 million; XPHOZAH net product sales revenue of $23.4 million Company ends Q1 with $214.0 [...]

89bio Reports First Quarter 2025 Financial Results and Corporate Updates

01/05/2025 - 22:05

– Topline histology data from ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials are expected in 1H 2027 and in 2028, respectively; each trial is designed to support accelerated approval to treat patients with [...]

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

01/05/2025 - 22:05

WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick , President, CEO and Chairman of the [...]

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

01/05/2025 - 22:05

Dosing cohort 3 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers and plan to initiate backfill cohorts in the second half of 2025 Plan to provide a proof of concept data readout in the first half of 2026 [...]

Kura Oncology Reports First Quarter 2025 Financial Results

01/05/2025 - 22:05

– NDA submitted in 1Q 2025 for ziftomenib for the treatment of adult patients with relapsed or refractory AML with an NPM1 mutation – – Data from Phase 1b/2 registration-directed trial of ziftomenib selected for oral [...]

Zevra Therapeutics to Participate in the Citizens Life Science Conference

01/05/2025 - 22:05

CELEBRATION, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra’s [...]

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

01/05/2025 - 22:05

SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]

Streamline Health® Announces New eValuator™ Contract with Ohio-Based Health System

01/05/2025 - 22:05

1,100 bed health system selects eValutor’s pre-bill code audit technology to improve coding accuracy ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of [...]

Stryker reports first quarter 2025 operating results

01/05/2025 - 22:05

Portage, Michigan, May 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2025: First Quarter Results Reported net sales increased 11.9% to $5.9 billion Organic net sales [...]

Option Care Health to Participate in Upcoming Investor Conferences

01/05/2025 - 22:05

BANNOCKBURN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will [...]

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025

01/05/2025 - 22:05

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , announced today that its first quarter 2025 financial results will be released before market open on [...]

Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information

01/05/2025 - 22:05

WESTBROOK, Maine, May 01, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it plans to release [...]

Sutro Biopharma to Participate in Upcoming Investor Conferences

01/05/2025 - 22:05

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), [...]

Amwell® Announces Results for First Quarter 2025

01/05/2025 - 22:05

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March [...]

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

01/05/2025 - 22:05

- Implementation of cost reduction initiatives to position Pliant for execution of late-stage clinical trials - Pliant will reduce its current workforce by approximately 45% - Closing activities for BEACON-IPF trial [...]

Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements

01/05/2025 - 22:05

Generated $78.3 million in net product sales of XDEMVY ® , an increase of 217% year over year and 18% over Q4 2024, and dispensed approximately 72,000 bottles to patients Strengthened financial position with [...]